|
|
|
|
|
by The_rationalist
1824 days ago
|
|
Well it was a simplification. I know that many dopamine releasing agents are safe, such as amantadine.
However when a drug is a DRA + a dopamine reuptake inhibitor or worse reverse the transport of dopamin reuptake through TRAAR and / or is a dopamin agonist then there is a risk of neurotoxicity and of durably lowering dopamin receptor density in the brain.
This also apply for other monoamines but to a lesser extent.
Most of drugs that have this combination of action are
https://en.m.wikipedia.org/wiki/Substituted_phenethylamine
Some are safe such as D-amphetamine (Adderall, Vyvanse) but most have an unknown risk.
Note that you can regrow lost receptors to some extent with e.g Uridine. |
|